As we head into the winter months, protecting older adults from preventable respiratory illness is more important than ever. CESPHN is encouraging eligible community members to access the new free Respiratory Syncytial Virus (RSV) vaccine, funded by the Australian Government under the National Immunisation Program from 15 May 2026.
Why vaccinate older Australians for RSV?
RSV is common – and can be severe in older people. RSV is a highly infectious respiratory virus that usually causes mild, cold‑like symptoms, but in older adults it can lead to severe disease. RSV can cause pneumonia and bronchitis and, in some cases, result in hospitalisation, intensive care admission or death. Older people, particularly those living in aged care or with chronic health conditions, are at higher risk due to reduced immunity and close living environments.
Why this matters for our community
This new RSV vaccination program reduces preexisting financial barriers to health care and complements existing free flu and COVID‑19 vaccines, strengthening protection for those most at risk of severe respiratory illness.
Vaccination not only protects individuals but helps reduce the spread of illness across the community—supporting healthier families, carers and aged care residences.
How do older Australians access the RSV vaccine?
From May 15, 2026, a free RSV vaccine is available for:
Eligible people can receive the vaccine through their GP, local immunisation clinic, community or Aboriginal health service, or participating pharmacy.
Community members are encouraged to speak with their healthcare provider about RSV vaccination and staying up to date with all recommended immunisations this winter.
See Department of Health, Disability and Aging media release here.
See National Immunisation Program RSV consumer fact sheet here.
Immunisation Weekly Update: Diphtheria: NSW Vaccination Recommendations NSW Health childhood vaccination campaign toolkit New respiratory syncytial virus (RSV) maternal vaccination resource Education Diphtheria: NSW Vaccination Recommendations NSW Health is reminding providers to check the diphtheria vaccination status of all Aboriginal people and offer vaccination where eligible. A NSW-funded vaccination program is currently available…
Immunisation Weekly Update: Promote Japanese Encephalitis Vaccination Ahead of Travel Measles Immunity Gaps: A Timely Reminder to Check Vaccine Status COVID-19 vaccination in 2026: preparing for the transition to the National Immunisation Program (NIP) Webinar Education Promote Japanese Encephalitis Vaccination Ahead of Travel Funded JE vaccination is available for eligible…
Immunisation Weekly Update: Capvaxive stock exhausted Current stocks of Capvaxive have been exhausted due to ongoing supply and distribution constraints, resulting in a temporary vaccine shortage. Further stock is anticipated to arrive in the coming weeks. Please ensure clinics or appointments for eligible patients are only booked when you have…
Immunisation Weekly Update: Capvaxive® supply constraints General practices are advised that there are currently national supply delays affecting Capvaxive® (adult pneumococcal vaccine). To help manage available stock, practices should only schedule vaccination appointments for eligible patients when adequate vaccine supplies are available on site. Supply constraints are expected to improve…
Immunisation Weekly Update: NSW Health Vaxigrip stock exhausted: temporary stock-sharing licence in place As of 20 July 2026, NSW Health has exhausted its available stock of Vaxgrip vaccine, which is funded for people aged 6 months to less than 5 years under the National Immunisation Program (NIP). NSW Health has…
Have you filled in CESPHN’s Stakeholder Survey? Help us find out more about how we can support you in 2027.
Take the survey (opens in new tab)
